“The science behind procrastination and how to overcome it”
By Study International Staff | September 27, 2018 | www.studyinternational.com
This article talks about research that suggests scientists may have identified a neurological component to procrastination. According to the article, a larger than average amygdala may contribute to higher anxiety and therefore hesitation. Another region (the dorsal interior cingulate cortex) usually helps us block out competing emotions, but the connections between this region and the amygdala were found to be poorer than with non-procrastinators. I.e., our brains get “overwhelmed with conflicting emotions and struggling to prioritize the task at hand.”Tim Pychyl, a researcher and expert on procrastination, says in the article that mindfulness meditation may be part of the answer because “research has already shown that mindfulness meditation is related to amygdala shrinkage, expansion of the prefrontal cortex, and a weakening of the connection between these 2 areas.”
Read the full article here.
Regular exercise can reduce risk for depression
By HealthDay News, April 26, 2018
Here’s one more reason to go biking, hiking, or whatever form of exercise you engage in. This article is about “the first global meta-analysis to establish that engaging in physical activities beneficial for protecting the general population from developing depression.” It doesn’t matter how old you are. It doesn’t matter where you live. Just get out there.
“Not Talking About Mental Health Is Literally Killing Men”
by Sean Evans, MensHealth.com, 5/2/18.
An interesting article about mental health stigma among men. The articles states, “Male suicide is rising at such an alarming rate that it’s been classified as a “silent epidemic.” It’s the seventh leading cause of death for males. That’s a staggering statistic…This macho attitude of stuffing your feelings down, or ignoring them, is antiquated and downright dangerous.” Read the full article here.
“Shire wins U.S. approval for long-acting ADHD drug” by Natalie Grover, Ben Hirschler of Reuters
Shire received approval for a new long-acting medication named Mydayis. It is the same as Adderall XR (i.e., amphetamine & dextroamphetamine mixed salts) but should last 16 hours, compared to Adderall XR’s 12 hours. Read more here.
“Depression Is Now the World’s Most Widespread Illness”
By Laura Entis as published online in Fortune.com, Mar 30, 2017
This article came out earlier this spring and gave some hard numbers on just how pervasive and destructive depression can be. Here are some of the key statistics.
- The World Health Organization (WHO) estimated that 322 million people were living with depression in 2015. That makes it the number one cause of ill health and disability worldwide.
- The majority of people suffering from depression are not receiving adequate care.
- Even in high income countries it is estimated that half of people suffering from depression did not receive treatment.
- The cost related to depression add up to $1 trillion annually by WHO estimates.